Development of a biocatalytic process as an alternative to the (-)-DIP-Cl-mediated asymmetric reduction of a key intermediate of montelukast
Access
DOI:
10.1021/op900272d
Citation
ID:
85770
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
85770
Unique Identifier:
10.1021/op900272d
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Blockchain Upload Locked
Complete all 5 checklist items to tokenize your article